Connective Tissue Peptides TRIZ Cases

Purified non-human meniscus collagen reduces disease transmission and bio-incompatibility while preserving structure for repair and integration.

Engineered 10Fn3 domains bind serum albumin to extend therapeutic half-life, reducing injection frequency, discomfort, and infection risk.

Organic acids, protease enzymes, nano-milling, and liquid nitrogen shorten collagen processing while lowering bioburden and raising yield.

By fusing GDNF variants to Fc, albumin-binding, or albumin domains, this case extends serum half-life while preserving GFRα1 activity.

C-terminal PmXn moieties help 10Fn3 fibronectin scaffold proteins retain target binding while improving thermostability and solubility.

A recombinant collagen peptide balances the Gly-X-Y motif with essential amino acids to improve nutritional adequacy without complex production.

By fusing TNFSF ligands to the SPD coiled-coil domain, this case improves receptor clustering, boosts T-cell responses, and limits systemic toxicity.

Combining native and denatured type I collagen in one injectable balances structural support and biological activity for tissue regeneration.

Signal peptides in C. glutamicum enable secretion of mature collagen-like proteins, avoiding protease cleavage and costly purification.

Vitronectin-coated serum-free culture boosts mesenchymal stem cell yield and purity from bone marrow while avoiding xenogeneic contamination.

Small EDB-binding cystine-knot miniproteins improve tumor penetration and imaging while reducing background signal and healthy-tissue toxicity.

Anti-elastin antibodies bind degraded elastic fibers to localize imaging or therapy payloads, reducing dose, off-target effects, and toxicity.

A protein scaffold with defined repeat sequences and secondary structure helps damaged meniscus tissue regenerate while maintaining a suitable wet state.

Low molecular weight hydrolyzed collagen with gelatin acts as a scaffold to speed wound healing, lower infection risk, and reduce scarring.

Recombinant collagen with tuned molecular weight and isoelectric point stays miscible with hyaluronic acid for stable dermal and skincare blends.

Site-specific cysteine FN3 binders target EGFR or c-Met while enabling homogeneous drug conjugation and reducing off-target toxicity.

Intermediate-filament peptides boost viral vector uptake in target cells, raising transduction yield while reducing MOI, cost, and safety burden.

Encapsulated DNA-tagged surrogates mimic pathogen behavior to verify produce wash water sanitation without using real pathogens.

Small FN3 binders replace bulky antibodies to target EpCAM with high affinity, improving tumor delivery and reducing systemic toxicity.

Fibronectin scaffold polypeptides target GPC3 to improve selective HCC detection and support drug conjugates that inhibit cancer cell growth.

Trimerizing peptide conjugates use symmetric spike binding to inhibit SARS-CoV-2 variants while improving affinity for antiviral therapy.

Non-invasive epithelial cells cultured on laminin in serum-free conditions improve iPS cell induction efficiency while reducing donor burden.

One-pot aqueous PISA forms amphiphilic peptide nanoparticles without toxic organic solvents, simplifying scale-up and purification.

By linking Fc-binding and integrin-binding domains, this case improves antibody retention in tumors and strengthens local anti-tumor activity.